Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study

Table 2 Characteristics in different categories of glucose regulation at baseline and after three years

	NGT (n= 142)		IFG (n= 86)		IGT (n= 62)		type 2 diabetes (n= 64)
	T0	T3	T0	T3	T0	T3	T0	T3
Use of medication
Antihypertensive drugs (%)	21.1	42.3	31.4	48.8	41.9	66.1	31.3	67.2*
Lipid lowering drugs (%)	14.8	32.4	17.4	27.9	14.5	32.3	14.1	56.3†
Acetylsalicylic acid (%)	9.2	19.7	16.3	22.1	11.3	22.6	9.4	15.6
Anthropometric characteristics
SBP (mm Hg)	147 ± 33	146 ± 20	151 ± 24	145 ± 23‡	160 ± 24	143 ± 21‡	156 ± 21	140 ± 13‡
DBP (mm Hg)	83 ± 20	84 ± 10	86 ± 11	82 ± 10‡	89 ± 12	80 ± 11‡	89 ± 9	80 ± 7‡

Data are presented as mean (± SD) except where otherwise specified.
T0, at baseline; T3, after three years; SBP, systolic blood pressure; DBP, diastolic blood pressure.
* Difference in use of medication at T3 and T0 in type 2 diabetes category significantly different from differences in NGT and IFG categories; † difference in use of medication at T3 and T0 in type 2 diabetes category significantly different from differences in all other categories; ‡ difference in mean in diagnostic category at T0 and T3 significant.

ISSN: 2731-4553